Pharmacovigilance Characteristics and Activities within the First Cohort of EU Risk Management Plans (RMPs): Small Molecules vs. Biologicals

被引：0
|
作者：
T. J. Giezen
A. K. Mantel-Teeuwisse
S. M. J. M. Straus
A. C. G. Egberts
I. Persson
H. G. M. Leufkens
机构：
[1] Utrecht Institute for Pharmaceutical Sciences (UIPS),Division of Pharmacoepidemiology and Pharmacotherapy
[2] Medicines Evaluation Board,Clinical Pharmacy
[3] University Medical Center Utrecht,undefined
[4] Medical Products Agency,undefined
来源：
Drug Safety | 2008年 / 31卷
关键词：
Medicinal Product; Safety Study; Nephrol Dial Transplant; CHMP; Risk Management Plan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：885 / 885
相关论文
共 2 条
  • [1] Pharmacovigilance Characteristics and Activities within the First Cohort of EU Risk Management Plans (RMPs): Small Molecules vs. Biologicals
    Giezen, T. J.
    Mantel-Teeuwisse, A. K.
    Straus, S. M. J. M.
    Egberts, A. C. G.
    Persson, I
    Leufkens, H. G. M.
    DRUG SAFETY, 2008, 31 (10) : 896 - 897
  • [2] Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory Approval
    Thijs J. Giezen
    Aukje K. Mantel-Teeuwisse
    Sabine M. J. M. Straus
    Toine C. G. Egberts
    Stella Blackburn
    Ingemar Persson
    Hubert G. M. Leufkens
    Drug Safety, 2009, 32 : 1175 - 1187
1